Fu, J., Franzen, N., Aas, E., Koen van der Mijn, J., van Leeuwen, P. J., & Retel, V. P. (2025). Early Cost-Effectiveness Analysis of Using Whole-Genome Sequencing for Patients With Castration-Resistant Prostate Cancer. Value in health, 28(5), 720-729. https://doi.org/10.1016/j.jval.2025.02.004
Chicago Style (17th ed.) CitationFu, Jinjing, Nora Franzen, Eline Aas, J.C Koen van der Mijn, Pim J. van Leeuwen, and Valesca P. Retel. "Early Cost-Effectiveness Analysis of Using Whole-Genome Sequencing for Patients With Castration-Resistant Prostate Cancer." Value in Health 28, no. 5 (2025): 720-729. https://doi.org/10.1016/j.jval.2025.02.004.
MLA (9th ed.) CitationFu, Jinjing, et al. "Early Cost-Effectiveness Analysis of Using Whole-Genome Sequencing for Patients With Castration-Resistant Prostate Cancer." Value in Health, vol. 28, no. 5, 2025, pp. 720-729, https://doi.org/10.1016/j.jval.2025.02.004.